from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3147/nuoC

LFCtreatmentdescriptionclass of inhibitor

-1.292

Amikacinug/mL Amikacintranslation

-1.446

Cap5-10ug/mL Capreomycintranslation

-2.406

Rox10-50 ug/mL Roxithromycintranslation

-0.552

SM2-5 ug/mL Streptomycintranslation

-4.252

Tet5-10 ug/mL Tetracyclinetranslation

-0.756

Rif0.2-5ug/mL Rifampicintranscription

-0.161

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.193

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.156

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.424

CPZ10-50 ug/mL Chlorpromazinerespiration

0.552

Clofazimine10-13 ug/mL Clofaziminerespiration

1.599

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.112

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.639

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.912

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.628

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.302

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.925

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.127

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.900

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.170

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

0.118

Nigericin50 uM Nigericinrespiration

-1.081

TRC10-150 ug/mL Triclosanrespiration

1.144

TRZ10-25 ug/mL Thioridazinerespiration

-0.337

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.118

menadione6-10 ug/mL Menadionerespiration

-1.311

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.553

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-1.059

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.120

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.422

NRP_1Non-replicating persistence stage 1dosRassociated

0.592

Amp0.2mg/mL AmpicillincellWall

0.430

Cephalexin20-100 ug/mL CephalexincellWall

-0.012

Cerulenin0.32-5 ug/mL CerulenincellWall

0.980

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.202

EMB10-20 ug/mL EthambutolcellWall

-0.379

Eta12-40 ug/mL EthionamidecellWall

-0.471

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.080

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.263

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.967

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.236

BZA0.12 mg/mL BenzamidearomaticAmides

0.100

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.341

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.574

H2O24 mM hydrogen peroxideDNAdamaging

0.240

Levo10 ug/mL LevofloxacinDNAdamaging

-0.055

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.341

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.237

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.525

UVUV-irradiationDNAdamaging

-0.044

ARP41-4 ug/mL Antitubercular compound ARP4?

0.571

Antimycin12.5-50 ug/mL Antimycin A?

0.169

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.461

PA_110-50 ug/mL Antitubercular compound PA-1?

0.594

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.338

PA8240.2-2 ug/mL PA-824?

-0.795

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.583

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.970

Verapamil50 uM Verapamil?

0.107

mercaptoethanol2 mM 2-Mercaptoethanol?

0.732

methoxatin10-20 ug/mL Methoxatin?